Biotransformation Research Advances – 2023 year in review

IF 3.4 2区医学 Q2 PHARMACOLOGY & PHARMACY

Drug Metabolism Reviews Pub Date : 2024-06-19 DOI:10.1080/03602532.2024.2370330

S.Cyrus Khojasteh, UpendraA Argikar, Maria Chatzopoulou, Lionel Cheruzel, Sungjoon Cho, Deepika Dhaware, KevinM Johnson, AmitS Kalgutkar, Joyce Liu, Bin Ma, Hlaing Maw, JessicaA Rowley, HeranaKamal Seneviratne, Shuai Wang

引用次数: 0

Abstract

This annual review marks the eighth in the series starting with Baillie et al. 2016. Our objective is to explore and share articles which we deem influential and significant in the field of biotran...

查看原文本刊更多论文

生物转化研究进展 - 2023 年回顾

从2016年的Baillie等人开始，本年度综述是该系列的第八篇。我们的目标是探讨和分享我们认为在生物技术领域具有影响力和重要意义的文章。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drug Metabolism Reviews 医学-药学

CiteScore

11.10

自引率

1.70%

发文量

审稿时长

1 months

期刊介绍： Drug Metabolism Reviews consistently provides critically needed reviews of an impressive array of drug metabolism research-covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, the journal offers new hypotheses of interest to diverse groups of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well as enzymologists working in xenobiotic biotransformation.